Kosmos Energy Ltd - Director/PDMR Shareholding

06/13/23 06:00 GMT

RNS Number : 4710C

Kosmos Energy Limited

13 June 2023

Kosmos Energy Ltd (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

13 June 2023

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR	Date of transaction	No. of shares vested	No. of shares granted	No. of shares sold or withheld
Roy A. Franklin	8 June 2023	0	24,964	0
Roy A. Franklin	9 June 2023	0	0	8,000
Deanna L. Goodwin	8 June 2023	0	24,964	0
Deanna L. Goodwin	9 June 2023	0	0	112,000
Sir John Douglas Kelso Grant	8 June 2023	0	24,964	0
Maria Moraeus Hanssen	8 June 2023	0	24,964	0
Adebayo O. Ogunlesi	8 June 2023	0	24,964	0
Steven M. Sterin	8 June 2023	0	24,964	0
J. Michael Stice	8 June 2023	0	24,964	0

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

Josh R. Marion

Vice President and Assistant Secretary

CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Roy A. Franklin
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Issuer's Long Term Incentive Plan (the "Plan") and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	8,000 shares sold on June 9, 2023 to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.80
	Volume	8,000
	Total	54,400
e)	Aggregated information
	Price	6.80
	Volume	8,000
	Total	54,400
f)	Date of the transactions	9 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Deanna L. Goodwin
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	112,000 shares sold on June 9, 2023 on the open market. The transaction was executed in multiple trades at prices ranging from USD 6.65 to USD 6.73. The price below of USD 6.69 reflects the weighted average purchase price.
Shares granted or vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.69
	Volume	112,000
	Total	749,280
e)	Aggregated information
	Price	6.69
	Volume	112,000
	Total	749,280
f)	Date of the transactions	9 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Sir John Douglas Kelso Grant
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Maria Moraeus Hanssen
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Adebayo O. Ogunlesi
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Steven M. Sterin
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	J. Michael Stice
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)	Currency	USD
	Price	6.81
	Volume	24,964
	Total	170,004.84
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.81
	Volume	24,964
	Total	170,004.84
f)	Date of the transactions	8 June 2023
g)	Place of the transaction	NYSE

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSFFFUEEDSEIM

Investors

News Release Details